Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
---|---|---|---|---|---|
IL5-PCFA1 | Human | PE-Labeled Monoclonal Anti-Human IL-15 Antibody, Mouse IgG1 (12B11E5) (0.03% Proclin) | |||
IL5-H5257 | Human | Human IL-15 Protein, Fc Tag (MALS verified) |
|
||
CRS-A024 | Human | resDetect™ Human Interleukin-15 (IL-15) ELISA Kit (Residue Testing) | |||
IL5-H5215 | Human | Human IL-15 Protein (HEK293), premium grade |
|
||
IL5-M543 | Mouse | Anti-Human IL-15 (9B5G1) mAb, Mouse IgG1 |
|
||
IL5-M542 | Mouse | Anti-Human IL-15 (12B11E5) mAb, Mouse IgG1 |
|
||
GMP-L15H13 | Human | GMP Human IL-15 Protein |
|
||
IL5-H82E3 | Human | Biotinylated Human IL-15 Protein, His,Avitag™ |
|
||
IL5-C52H4 | Cynomolgus / Rhesus macaque | Cynomolgus / Rhesus macaque IL-15 Protein, His Tag |
|
||
IL5-H52H8 | Human | Human IL-15 Protein, His Tag (MALS verified) |
|
||
IL5-M5255 | Mouse | Mouse IL-15 Protein, Fc Tag |
|
||
IL5-H82F3 | Human | Biotinylated Human IL-15 Protein, Fc,Avitag™ (MALS verified) |
|
||
IL5-M82F3 | Mouse | Biotinylated Mouse IL-15 Protein, Fc,Avitag™ |
|
||
IL5-H4117 | Human | Human IL-15 Protein (E. coli), premium grade |
|
Human IL-15 Protein, Fc Tag (Cat. No. IL5-H5257) stimulates proliferation of CTLL-2 cells. The typically EC50 for this effect is 2.483 ng/mL (QC tested).
Biotinylated Human IL-15 R alpha, Fc,Avitag (Cat. No. ILA-H82F4) immobilized on CM5 Chip can bind Human IL-15 Protein, Fc Tag (Cat. No. IL5-H5257) with an affinity constant of 27.7 pM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
BNZ-1 | BNZ132-1-40; BNZ-1; BNZ132-1; BNZ-01; EQ101; EQ-101 | Phase 2 Clinical | Bioniz Therapeutics Inc | Alopecia; Alopecia Areata; Lymphoma, T-Cell, Cutaneous; Leukemia, Large Granular Lymphocytic | Details |
Ordesekimab | HuMab-IL15; AMG-714; PRV-015 | Phase 2 Clinical | Provention Bio Inc, Genmab A/S, Amgen Inc | Arthritis, Rheumatoid; Celiac Disease; Psoriasis; Lymphoma, T-Cell; Vitiligo | Details |
HCW-9218 | HCW-9218 | Phase 2 Clinical | HCW Biologics Inc | Solid tumours; Pancreatic Neoplasms; Pulmonary Fibrosis | Details |
NY-ESO-1 TCR/IL-15 NK | Phase 2 Clinical | The University Of Texas MD Anderson Cancer Center, Syena, Replay Holdings LLC | Sarcoma, Synovial; Multiple Myeloma; Liposarcoma, Myxoid | Details | |
IL15-transpresenting WT1-targeted Dendritic Cell Vaccine(Antwerp University Hospital) | Phase 2 Clinical | Antwerp University Hospital | Liver Neoplasms; Ovarian Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms | Details | |
CAR-5/IL-15-transduced CB-NK cell therapy | Phase 2 Clinical | The University Of Texas MD Anderson Cancer Center | Hematologic Neoplasms | Details | |
Recombinant Human IL12/15-PDL1B Herpes Simplex Type I Oncolytic Virus(CNBG) | VG-161 | Phase 2 Clinical | Cnbg-Virogin Biotech (Shanghai) Ltd | Solid tumours; Liver Neoplasms; Biliary Tract Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Pancreatic Neoplasms; Sarcoma; Cholangiocarcinoma; Carcinoma, Hepatocellular | Details |
XmAb24306 | XmAb-24306; RG-6323; RO-7310729; XmAb-306 | Phase 1 Clinical | Genentech Inc, Xencor Inc | Solid tumours; Neoplasms; Multiple Myeloma | Details |
SIM-0237 | SIM-0237 | Phase 1 Clinical | Simcere Pharmaceutical Group Ltd | Solid tumours; Urinary Bladder Neoplasms | Details |
CYTO-102 | CYTO-NK-102; CYTO-102; COH06 | Phase 1 Clinical | CytoImmune Therapeutics Inc | Lung Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
VG-201 | VG-201 | Phase 1 Clinical | ViroGin Biotech Ltd | Solid tumours; Stomach Neoplasms; Esophageal Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
VG-203 | VG-203; VG2062; VG-2062 | Phase 1 Clinical | ViroGin Biotech Ltd, Shanghai Funuojian Biotechnology Co Ltd, Virogin Biotech (Shenzhen) Ltd, Fenojian Biotechnology (Nantong) Co Ltd | Ovarian Neoplasms; Solid tumours; Carcinoma, Renal Cell; Breast Neoplasms | Details |
ACTM-838 | ACTM838 | Phase 1 Clinical | Actym Therapeutics Inc | Solid tumours | Details |
CALY-002 | CALY-002 | Phase 1 Clinical | Idd Biotech | Eosinophilic Esophagitis; Celiac Disease | Details |
This web search service is supported by Google Inc.